Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease.
- Duvoisin G Department of Paediatrics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Lopez RN Department of Gastroenterology, Sydney Children's Hospital Randwick, Sydney, Australia.
- Day AS Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.
- Lemberg DA Department of Gastroenterology, Sydney Children's Hospital Randwick, Sydney, Australia.
- Gearry RB Department of Paediatrics, University of Otago, Christchurch, Christchurch, New Zealand.
- Leach ST School of Women's and Children's Health, University of New South Wales, Sydney, NSW, Australia.
- 2017-05-20
Published in:
- Mediators of inflammation. - 2017
English
There is increasing importance placed upon noninvasive assessment of gut inflammation. These tools are likely to be the key in differentiating intestinal inflammatory disease from functional disorders and in monitoring the response to intervention in individuals with known inflammatory conditions. Although various noninvasive markers are currently available, they have limitations and do not provide ideal utility. This review focuses on emerging markers of gut inflammation, highlighting the potential of specific markers.
- Language
-
- English
- Open access status
- gold
- Identifiers
-
- DOI 10.1155/2017/1936315
- PMID 28522897
- Persistent URL
- https://sonar.ch/global/documents/117265
Statistics
Document views: 6
File downloads:
- fulltext.pdf: 0